Search Results

Aspirin/nicorandil/ticlopidine/cilostazol: Cholestatic-type liver injury treated with ursodeoxycholic acid/plasma exchange and cilostazol-related increase in pulse rate: case report

Source: Reactions, Volume 1, Number 1278, 2009-11-14 , pp. 9-10(2)

Publisher: Adis International

Sirolimus: Stent thrombosis following cilostazol withdrawal in an elderly patient: case report

Source: Reactions, Volume 1, Number 1272, 2009-10-03 , pp. 29-29(1)

Publisher: Adis International

Triple antiplatelet therapy vs. dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: an evidence-based approach to answering a clinical query

Authors: Singh, Inderjeet; Shafiq, Nusrat; Pandhi, Promila; Reddy, Srinivas; Pattanaik, Smita; Sharma, Yashpaul; Malhotra, Samir

Source: British Journal of Clinical Pharmacology, Volume 68, Number 1, July 2009 , pp. 4-13(10)

Publisher: Blackwell Publishing

Cilostazol: Collagenous colitis (first report) in an elderly patient: case report

Source: Reactions, Volume 1, Number 1254, 2009-05-30 , pp. 16-16(1)

Publisher: Adis International

Current Management of Intermittent Claudication: The Role of Pharmacological and Nonpharmacological Symptom-Directed Therapies

Authors: Mangiafico, Roberto A.; Fiore, Carmelo E.

Source: Current Vascular Pharmacology, Volume 7, Number 3, July 2009 , pp. 394-413(20)

Publisher: Bentham Science Publishers

Update on oral antiplatelet therapy: principles, problems and promises

Authors: Grove, Erik L; Kristensen, Steen D

Source: Future Cardiology, Volume 5, Number 3, May 2009 , pp. 247-258(12)

Publisher: Future Medicine

A Review of Cilostazol, a Phosphodiesterase Inhibitor, and its Role in Preventing Both Coronary and Peripheral Arterial Restenosis Following Endovascular Therapy

Authors: Dindyal, Shiva; Kyriakides, Constantinos

Source: Recent Patents on Cardiovascular Drug Discovery, Volume 4, Number 1, January 2009 , pp. 6-14(9)

Publisher: Bentham Science Publishers

The Renal Protective Effects of Cilostazol on Suppressing Pathogenic Thrombospondin-1 and Transforming Growth Factor-β Expression in Streptozotocin-induced Diabetic Rats

Authors: Wang, X.; Yan, L.; Chen, W.; Xu, L.; Zhang, X.

Source: The Journal of International Medical Research, Volume 37, Number 1, January 2009 , pp. 145-153(9)

Publisher: Field House Publishing

Aspirin/cilostazol/clopidogrel: Lack of efficacy in preventing stent thrombosis, following placement of sirolimus-eluting stent: case report

Source: Reactions, Volume 1, Number 1231, 2008-12-06 , pp. 6-6(1)

Publisher: Adis International

Antiplatelet Agents Sarpogrelate and Cilostazol Affect Experimentally-induced Ventricular Arrhythmias and Mortality

Authors: Barta, Judit; Sanganalmath, Santosh; Kumamoto, Hideo; Takeda, Nobuakira; Édes, István; Dhalla, Naranjan

Source: Cardiovascular Toxicology, Volume 8, Number 3, September 2008 , pp. 127-135(9)

Publisher: Humana Press

Cilostazol and peripheral arterial disease

Authors: Pearce, Lyndsay; Ghosh, Jonathan; Counsell, Andrew; Serracino-Inglott, Ferdinand

Source: Expert Opinion on Pharmacotherapy, Volume 9, Number 15, October 2008 , pp. 2683-2690(8)

Publisher: Informa Healthcare

Platelet Activation, and Antiplatelet Targets and Agents: Current and Novel Strategies

Authors: Xiang, Yao-Zu; Xia, Ye; Gao, Xiu-Mei; Shang, Hong-Cai; Kang, Li-Yuan; Zhang, Bo-Li

Source: Drugs, Volume 68, Number 12, 2008 , pp. 1647-1664(18)

Publisher: Adis International

Cilostazol/glycyrrhizin interaction: First report of an interaction, leading to pseudoaldosteronism in an elderly patient: case report

Source: Reactions, Volume 1, Number 1214, 2008-08-09 , pp. 12-13(2)

Publisher: Adis International

Cilostazol may be useful after PCI, based on meta-analysis

Source: Inpharma, Volume 1, Number 1648, 2008-07-26 , pp. 14-14(1)

Publisher: Adis International

Tissue-specific expression of PPAR mRNAs in diabetic rats and divergent effects of cilostazol

Authors: Wang, Furong; Gao, Ling; Gong, Bendi; Hu, Jianting; Li, Mei; Guan, Qingbo; Zhao, Jiajun

Source: Canadian Journal of Physiology and Pharmacology, Volume 86, Number 7, 1 July 2008 , pp. 465-471(7)

Publisher: NRC Research Press

Effects of Cilostazol on Thrombospondin-1 (TSP-1) Expression Changes in the Myocardium of Diabetic Rats

Authors: Ma, J.; Zheng, M.; Shen, Y.; Wang, L.; Zhu, Y.; Zhang, X.

Source: The Journal of International Medical Research, Volume 36, Number 4, July 2008 , pp. 800-809(10)

Publisher: Field House Publishing

ANTIPLATELET CILOSTAZOL, AN INHIBITOR OF TYPE III PHOSPHODIESTERASE, IMPROVES SWALLOWING FUNCTION IN PATIENTS WITH A HISTORY OF STROKE

Authors: Teramoto, Shinji; Yamamoto, Hiroshi; Yamaguchi, Yasuhiro; Ishii, Masaki; Hibi, Shinichiro; Kume, Haruki; Ouchi, Yasuyoshi

Source: Journal of the American Geriatrics Society, Volume 56, Number 6, June 2008 , pp. 1153-1154(2)

Publisher: Blackwell Publishing

Antiplatelet therapy mitigates cardiac remodeling and dysfunction in congestive heart failure due to myocardial infarction

Authors: Sanganalmath, Santosh K.; Barta, Judit; Takeda, Nobuakira; Kumamoto, Hideo; Dhalla, Naranjan S.

Source: Canadian Journal of Physiology and Pharmacology, Volume 86, Number 4, 1 April 2008 , pp. 180-189(10)

Publisher: NRC Research Press

Cilostazol + aspirin prevents in-stent restenosis in diabetics

Source: Inpharma, Volume 1, Number 1627, 2008-03-01 , pp. 10-10(1)

Publisher: Adis International

Cilostazol reduces adverse outcome risk in atherothrombosis

Source: Inpharma, Volume 1, Number 1627, 2008-03-01 , pp. 12-12(1)

Publisher: Adis International